News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,868 Results
Type
Article (39230)
Company Profile (281)
Press Release (647357)
Section
Business (204129)
Career Advice (1989)
Deals (35413)
Drug Delivery (85)
Drug Development (80985)
Employer Resources (169)
FDA (16132)
Job Trends (14821)
News (345075)
Policy (32491)
Tag
Academia (2546)
Alliances (49180)
Alzheimer's disease (1228)
Approvals (16063)
Artificial intelligence (131)
Bankruptcy (352)
Best Places to Work (11549)
Biotechnology (201)
Breast cancer (120)
Cancer (1082)
Cardiovascular disease (97)
Career advice (1659)
Cell therapy (232)
Clinical research (64378)
Collaboration (386)
Compensation (197)
COVID-19 (2534)
C-suite (94)
Data (1122)
Diabetes (152)
Diagnostics (6148)
Earnings (84868)
Employer resources (147)
Events (109750)
Executive appointments (308)
FDA (16663)
Funding (347)
Gene therapy (177)
GLP-1 (574)
Government (4341)
Healthcare (18706)
Infectious disease (2618)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16319)
Job creations (3627)
Job search strategy (1417)
Layoffs (416)
Legal (7861)
Lung cancer (170)
Manufacturing (176)
Medical device (13195)
Medtech (13200)
Mergers & acquisitions (19165)
Metabolic disorders (399)
Neuroscience (1505)
NextGen Class of 2024 (6513)
Non-profit (4477)
Northern California (1474)
Obesity (228)
Opinion (183)
Patents (101)
People (56330)
Phase I (19994)
Phase II (28353)
Phase III (21150)
Pipeline (454)
Postmarket research (2559)
Preclinical (8511)
Radiopharmaceuticals (235)
Rare diseases (218)
Real estate (5902)
Regulatory (21550)
Research institute (2320)
Resumes & cover letters (349)
Southern California (1299)
Startups (3577)
United States (13401)
Vaccines (549)
Weight loss (166)
Date
Today (133)
Last 7 days (796)
Last 30 days (3744)
Last 365 days (35661)
2024 (32654)
2023 (40146)
2022 (51264)
2021 (55795)
2020 (54188)
2019 (46648)
2018 (35118)
2017 (32201)
2016 (31564)
2015 (37642)
2014 (31409)
2013 (26431)
2012 (28614)
2011 (29319)
2010 (27370)
Location
Africa (714)
Arizona (192)
Asia (37262)
Australia (6098)
California (3311)
Canada (1282)
China (248)
Colorado (143)
Connecticut (150)
Europe (80122)
Florida (455)
Georgia (116)
Illinois (338)
Indiana (196)
Kansas (96)
Maryland (573)
Massachusetts (2592)
Michigan (157)
Minnesota (271)
New Jersey (950)
New York (950)
North Carolina (705)
Northern California (1474)
Ohio (138)
Pennsylvania (840)
South America (1094)
Southern California (1299)
Texas (458)
Utah (90)
Washington State (357)
686,868 Results for "h3 biomedicine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Innovent Provides Interpretation and Updates on Clinical Data from Mazdutide GLORY-1 Study and General Biomedicine Pipeline
Innovent Biologics, Inc. provided interpretation and updates on clinical data from Mazdutide’s GLORY-1 study and its general biomedicine pipeline at an investor conference call on June 25.
June 27, 2024
·
9 min read
Biotech Beach
Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines
Endeavor BioMedicines, Inc. today announced the closing of a $132.5 million Series C financing, including the conversion of a $5 million convertible instrument.
April 24, 2024
·
4 min read
Genetown
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference
Akebia Therapeutics today announced that John Butler , Chief Executive Officer, will participate in the H.C. Wainwright 3rd Annual Kidney Virtual Conference on Monday, July 15, 2024.
June 27, 2024
·
1 min read
Press Releases
Bio-Path Holdings Announces Publication in Biomedicines
September 16, 2024
·
4 min read
Business
Sail Biomedicines Appoints Clinical and Scientific Leader Dr. Wendy Chung to Its Board
Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Wendy Chung, M.D., Ph.D., has joined Sail’s Board of Directors.
April 2, 2024
·
2 min read
Business
Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. to Board of Directors
Endeavor BioMedicines announced that the company has appointed Enoch Kariuki, Pharm.D. to the Endeavor BioMedicines Board of Directors.
December 19, 2023
·
2 min read
Press Releases
First Patient Dosed in Endeavor BioMedicines’ Phase 2b WHISTLE-PF Trial Evaluating ENV-101 for the Treatment of Idiopathic Pulmonary Fibrosis
November 20, 2024
·
3 min read
Policy
USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA, announced the U.S. Department of Agriculture approval of NOBIVAC® NXT Canine Flu H3N2, a next-level solution to help safeguard dogs against the ongoing threat of canine influenza.
June 25, 2024
·
6 min read
Business
BioStem Technologies, Inc. to Present at the H.C. Wainwright 26th Annual Global Investment Conference in New York on September 9th at 3:30 PM ET
August 29, 2024
·
5 min read
Business
Endeavor BioMedicines Announces Appointment of Chris Krueger, J.D., as Chief Operating Officer
Endeavor BioMedicines today announced the appointment of Chris Krueger, J.D., as Chief Operating Officer (COO). Mr. Krueger brings extensive experience from the life sciences industry that will be instrumental to Endeavor’s continued growth and success.
April 16, 2024
·
2 min read
1 of 68,687
Next
